Recent studies have shown that genomic instability in cancer benefits cancer immunotherapy, as it determines the immunogenicity of tumor cells through mechanisms including activating the cytosolic innate immunity mediated mainly by the cGAS-STING pathway22. The gene discussed is STING1; the disease is cancer.